Publications published since 2020 from OUS - Department of Haematology

607 publications found

Publications 2026

1. Akin C, Sabato V, Gotlib J, Panse J, Álvarez-Twose I, Radia DH, Livideanu CB, Jurcic J, Elberink HO, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Hartmann K et al. (2026)
   Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
   J Allergy Clin Immunol, 158 (2), 421-431
   DOI 10.1016/j.jaci.2026.04.001, PubMed 41985569
2. Alnes SR, Laerum-Onsager E, Bye A, Vistven A, Franzén E, Holst M, Brovold T (2026)
   Post-rehabilitation self-management support on physical activity and nutrition, including mHealth, improves physical capacity, physical activity, and health related quality of life in people with Parkinson's- results from a randomised controlled trial
   Int J Behav Nutr Phys Act, 23 (1)
   DOI 10.1186/s12966-026-01888-y, PubMed 41703544
3. Andresen B, Oma Ohnstad M, Larsen MH, A Steindal S, Brun H, Eriksen KO, Hofsø K, Jenssen U, Wallander Karlsen MM, Kvande ME, L Mariussen K, Moons P, Sifa Nsengi C, J Skaarud K, Skedsmo K, Sørensen K, S Strøm B, Aamodt IT (2026)
   Effectiveness of eHealth Interventions for Adolescents and Young Adults With Congenital Heart Disease: Systematic Review
   J Med Internet Res, 28, e91424
   DOI 10.2196/91424, PubMed 42417451
4. Arrieta-Bolaños E, Bonneville EF, Crivello P, Gedde-Dahl T, Peffault de Latour R, Salmenniemi U, Kröger N, Yakoub-Agha I, Zecca M, Choi G, Crawley C, Tholouli E, Dubois V, Peräsaari J, Wieten L, Marsh SGE, Bengtsson M, Hoogenboom JD, Kuball J, Malard F, Ruggeri A, Fleischhauer K (2026)
   Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell Transplantation
   HLA, 107 (3), e70637
   DOI 10.1111/tan.70637, PubMed 41811229
5. Asady E, Jelsness-Jorgensen LP, Ghanima W, Klok FA, Kahn SR, Boon GJAM, Ende-Verhaar Y, Sequeira C, Wik HS (2026)
   Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter study
   Res Pract Thromb Haemost, 10 (3), 103443
   DOI 10.1016/j.rpth.2026.103443, PubMed 42079674
6. Bakken M, Kallager MR, Larsen MH, Steindal SA, Skaarud KJ (2026)
   Frailty in Patients With Hematologic Malignancies and Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review
   Cancer Rep (Hoboken), 9 (1), e70456
   DOI 10.1002/cnr2.70456, PubMed 41517864
7. Bertamini L, Fokkema C, Rodriguez-Otero P, van Duin M, Terpos E, D'Agostino M, van der Velden VHJ, van de Donk NWCJ, Delforge M, Driessen C, Hajek R, Einsele H, Vangsted A, Vieyra D, Attar R, Sitthi-Amorn A, Carson R, Schjesvold F, Robak P, Beksac M, Spencer A, Broijl A, Cupedo T, Moreau P, Boccadoro M et al. (2026)
   Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
   Blood, 147 (4), 431-442
   DOI 10.1182/blood.2025030113, PubMed 41060326
8. Brunetti M, Andersen K, Tjønnfjord GE, Zeller B, Spetalen S, Munthe-Kaas MC, Osnes LTN, Os TT, Micci F (2026)
   The NFIA::CBFA2T3 identifies a molecularly defined subgroup of acute erythroid leukemia/erythroid sarcoma
   Front Oncol, 16, 1809156
   DOI 10.3389/fonc.2026.1809156, PubMed 42158426
9. Cavo M, Schjesvold F, Dimopoulos M, Delforge M, Escalante F, Kleinman D, Lee HC, Vij R, Greil R, Melchardt T, Antonioli E, Lysen A, Camadoo-O'Byrne L, Bitetti J, D'Estrube T, Fry M, Byrne J, Vossen CY, Sapra S, Benson VS, Mouro J, Hultcrantz M (2026)
   Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/ refractory multiple myeloma treated in Europe
   Haematologica, 111 (7), 2488-2493
   DOI 10.3324/haematol.2025.289034, PubMed 41568469
10. Desai N, Tourigny JF, Chen C, Remberger M, Mattsson J, Ahmad I, Pasic I (2026)
    Early Initiation of Defibrotide is Associated With Better Survival in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Adults: Experience From Two Canadian Centers
    Transplant Cell Ther, 32 (8), 966.e1-966.e9
    DOI 10.1016/j.jtct.2026.04.034, PubMed 42049137
11. Dhayyat A, Stavem K, Jervan Ø, Hilde JM, Rashid D, Gleditsch J, Ghanima W, Steine K (2026)
    Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease
    Pulm Med, 2026, 4127338
    DOI 10.1155/pm/4127338, PubMed 41623859
12. Dimopoulos MA, Boccadoro M, Einsele H, Rodriguez-Otero P, Hulin C, Perrot A, Leleu X, Caillot D, Facon T, Mina R, Gay F, Broijl A, Hajek R, Spencer A, Schjesvold F, Zweegman S, Nair S, Ammann E, He J, Nobrega M, Rowe M, Sitthi-Amorn A, Sonneveld P (2026)
    Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
    J Med Econ, 29 (1), 421-430
    DOI 10.1080/13696998.2026.2624972, PubMed 41701105
13. Dimopoulos MA, Schjesvold F, Fu C, Hartley-Brown MA, Gomez C, Reece D, Mikala G, Alkharabsheh O, Parrish C, de Queiroz Crusoé E, Gálvez K, Idrobo H, White D, Gupta R, Lee C, Liu CJ, Quach H, Wang Y, Cerchione C, Forsyth C, Hungria V, Kalaskar P, Graklanov V, Ho PJ, Klaiber-Hakimi M et al. (2026)
    Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial
    Lancet, 408 (10551), 219-233
    DOI 10.1016/S0140-6736(26)01088-3, PubMed 42289183
14. Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J (2026)
    TCR T cells targeting IgA- and IgG-expressing multiple myeloma
    Blood (in press)
    DOI 10.1182/blood.2025031897, PubMed 41770814
15. Drozd-Sokolowska J, Gras L, Baaij LGA, Koster L, Nicholson E, Dreger P, Gedde-Dahl T, Mielke S, Salmenniemi U, Basak G, Chevallier P, Wulf GG, Schetelig J, Johansson JE, Nagler A, Quoc SN, Potter V, Sala E, Sandstedt AB, Koc Y, Zeiser R, Van Gelder M, Jedrzejczak WW, Raj K, McLornan DP et al. (2026)
    Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMT
    Haematologica (in press)
    DOI 10.3324/haematol.2025.288819, PubMed 42021691
16. Gay F, Roeloffzen W, Dimopoulos MA, Rosiñol L, van der Klift M, Mina R, Oriol A, Katodritou E, Wu KL, Rodríguez Otero P, Hájek R, Antonioli E, van Duin M, D'Agostino M, Martínez-López J, van Leeuwen-Segarceanu EM, Zamagni E, van de Donk NWCJ, Weisel KC, Pour L, Radocha J, Belotti A, Schjesvold F, Bladé J, Einsele H et al. (2026)
    Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
    Nat Med, 32 (5), 1773-1782
    DOI 10.1038/s41591-026-04282-0, PubMed 41942646
17. Gervin K, Kverneland M, Nakken KO, Rudi K, Iversen PO, Landmark CJ, Selmer KK (2026)
    DNA methylation of antiseizure medication metabolism genes and pharmacokinetic changes in adult epilepsy patients treated with the modified Atkins diet
    Genes Nutr, 21 (1)
    DOI 10.1186/s12263-026-00796-x, PubMed 41826818
18. Gotlib J, Reiter A, Radia DH, Álvarez-Twose I, Deininger MW, George TI, Panse J, Mital A, Pettit KM, Vannucchi AM, Platzbecker U, Hermine O, Elshoury A, Livideanu CB, Mesa R, Ustun C, Triggiani M, Dybedal I, Jurcic JG, Zanotti R, Oh ST, Yacoub A, Hexner EO, Bose P, Lee SG et al. (2026)
    Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
    Blood Adv, 10 (10), 3676-3689
    DOI 10.1182/bloodadvances.2025017519, PubMed 41604606
19. Gundesen MT, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Madsen JS, Asmussen JT, Teodorescu EM, Jensen BA, Slørdahl TS, Nielsen AA, Olsen DA, Søe K, Nahi H, Waage A, Abildgaard N, Schjesvold F, Lund T (2026)
    Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers
    Br J Haematol (in press)
    DOI 10.1111/bjh.70612, PubMed 42581608
20. Hakkarainen M, Sicre de Fontbrune F, Kaaja I, Douglas S, Dalle JH, Risitano AM, Kulasekararaj A, Alsultan A, Cutler C, Ho VT, Hellström-Lindberg E, Mielke S, Myhre AE, Rihani R, Shanap MA, Hashem H, Shimamura A, Rowe RG, Auer F, Beier F, Desnica L, Hough R, Ali Jafri SR, Ayas M, Jardine L et al. (2026)
    Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease
    Blood Adv, 10 (7), 2525-2537
    DOI 10.1182/bloodadvances.2025018349, PubMed 41628318
21. Hermansen JU, Yin Y, Tjønnfjord GE, Mato AR, Skånland SS (2026)
    Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia
    Br J Haematol, 209 (2), 469-479
    DOI 10.1111/bjh.70603, PubMed 42267774
22. Hermine O, Debeaupuis O, Damaj G, Lübke J, Schwaab J, Heizmann M, Siebenhaar F, Pyatilova P, Nojarov N, Niedoszytko M, Gorska A, Mattsson M, Shoumariyeh K, de Bra S, Wortmann F, von Bubnoff N, Bumbea H, Soare D, Elena C, Várkonyi J, Fortina AB, Erdem S, Brockow K, Franz TM, Panse J et al. (2026)
    Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study
    J Hematol Oncol (in press)
    DOI 10.1186/s13045-026-01819-1, PubMed 42363232
23. Iversen PO, Ali MM, Bastani NE, Blomhoff R, Tjønnfjord GE, Gedde-Dahl T (2026)
    Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial
    EJHaem, 7 (3), e70296
    DOI 10.1002/jha2.70296, PubMed 42137823
24. Kjendbakke I, Selmer KK, Nakken KO, Hofoss D, Iversen PO, Kverneland M (2026)
    Micronutrient intake in adults with drug-resistant epilepsy treated with the modified Atkins diet needs monitoring
    Front Nutr, 13, 1797011
    DOI 10.3389/fnut.2026.1797011, PubMed 42180576
25. Klevmoen M, van Lennep JR, Bogsrud MP, Vesterbekkmo EK, Pedersen EKR, Hovland A, Mulder JWCM, Brekke HK, Iversen PO, Vaclová M, Vrablík M, Freiberger T, Retterstøl K, Holven KB (2026)
    Extensive pregnancy-related off-treatment time in women with familial hypercholesterolaemia
    Atherosclerosis, 415, 120668
    DOI 10.1016/j.atherosclerosis.2026.120668, PubMed 41740525
26. Ktoridou-Valen I, Lenartova A, Grøndal SM, Wogsland CE, Dowrick AS, Wood M, Smerud KT, Meland N, Dahl T, Fesler A, Ju J, Gjertsen BT (2026)
    Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia
    Leukemia (in press)
    DOI 10.1038/s41375-026-03054-6, PubMed 42457875
27. König M, Holmøy T, Nygaard GO, Riise J, Midtvedt K, Goll GL, Jørgensen KK, Munthe LA, Fevang B, Myhre AE, Trøseid M (2026)
    Vaccination of immunosuppressed patients
    Tidsskr Nor Laegeforen, 146 (5)
    DOI 10.4045/tidsskr.25.0555, PubMed 42012114
28. Ludwig H, Terpos E, Gay F, van de Donk NWCJ, Bernhard S, Engelhardt M, Cook G, Schjesvold F, Einsele H, Jackson G, Pawlyn C, Mateos MV, Zweegman S, Schreder M, Beksaç M, Driessen C, Ocio EM, Popat R, Rasche L, Touzeau C, Musto P, Broijl A, Dimopoulos M, Hajek R, Boccadoro M et al. (2026)
    The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)
    Am J Hematol, 101 (9), 2353-2370
    DOI 10.1002/ajh.70397, PubMed 42315477
29. Malard F, Peric Z, Ruggeri A, Gedde-Dahl T, Bazarbachi A, Ciceri F, Mehra V, Blaise D, Kinsella F, Schoemans H, Sanz J, Bonifazi F, de Witte M, Morsink L, Duarte R, Spyridonidis A, Tavori G, Greinix HT, Nagler A, Holler E, Zeiser R, Mohty M (2026)
    Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement
    Bone Marrow Transplant, 61 (4), 373-384
    DOI 10.1038/s41409-026-02817-0, PubMed 41795054
30. Matlary RED, Holme PA, Rueegg CS, Glosli H, Grydeland M (2026)
    Comparison of IPAQ-SF Self-Reported and Fitbit-Measured Physical Activity in Young People With Haemophilia
    Haemophilia, 32 (3), 854-858
    DOI 10.1111/hae.70243, PubMed 41818433
31. Myhre AE, Meyer-Myklestad MH, Gullaksen HH, Søgaard OS, Tolstrup M, Salgado M, Martinez-Picado J, Holberg-Petersen M, Juhl AK, Schleimann MH, Gunst JD, Thomsen A, Fisher K, Bhamra JS, Kran AB, Halvorsen B, Dyrhol-Riise AM, Reikvam DH, Aukrust P, Gedde-Dahl T, Oslo HIV Cure Study Group, Dahl TB, Kaarbø M, Trøseid M (2026)
    Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor
    Nat Microbiol, 11 (5), 1374-1386
    DOI 10.1038/s41564-026-02304-8, PubMed 41975092
32. Måseide RJ, Berntorp E, Tjønnfjord GE, Holme PA (2026)
    Von Willebrand disease
    Tidsskr Nor Laegeforen, 146 (4)
    DOI 10.4045/tidsskr.25.0703, PubMed 41891463
33. Måseide RJ, Berntorp E, Tjønnfjord GE, Holme PA (2026)
    Rettelse: Von Willebrands sykdom
    Tidsskr Nor Laegeforen, 146
    DOI 10.4045/tidsskr.26.0234, PubMed 41891506
34. Norseth HML, Askeland FB, Abrahamsen I, Schjesvold F (2026)
    Resetting Sensitivity to T Cell Redirection by Tumor Reduction and Immune Modulation
    Clin Lymphoma Myeloma Leuk, 26 (4), 244-248
    DOI 10.1016/j.clml.2026.01.005, PubMed 41656130
35. Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Monsen HB, Schjesvold F (2026)
    High-dose melphalan and autologous haematopoietic stem cell transplantation in multiple myeloma in Norway, 2008-2020
    Tidsskr Nor Laegeforen, 146 (5)
    DOI 10.4045/tidsskr.25.0498, PubMed 42012109
36. Oldenburg J, Tiede A, Alamelu J, Álvarez Román MT, Bidlingmaier C, Holme PA, Peyvandi F, Bednar E, Nüesch E, Lethagen S (2026)
    Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories
    TH Open, 10, a28945837
    DOI 10.1055/a-2894-5837, PubMed 42591965
37. Orf K, Yousuf HA, Fox TA, Samsudeen N, Elcombe S, Campbell M, Jolles S, Conlon N, Chopra C, Tjon JM, Tholouli E, Thomas M, Devlin L, Stockdale C, Huissoon A, Tvedt TH, McDermott E, Storrar N, Hunter H, Ferrua F, Ghanta H, Neth O, Codero E, Mistry A, Shields A et al. (2026)
    Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-026-02941-x, PubMed 42432171
38. Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2026)
    Corrigendum to "Intake of a protein-enriched milk and effects on muscle mass and strength. A 12-week randomized placebo controlled trial among community-dwelling older adults" [J Nutr Health Aging, 21 (2017) 1160-69]
    J Nutr Health Aging, 30 (6), 100875
    DOI 10.1016/j.jnha.2026.100875, PubMed 42140071
39. Pati NB, Chung BK, Holm K, Sætre F, Reims HM, Aasebo AT, Gedde-Dahl T, Sreelakshmi KV, Domanska D, Hov JR, Bækkevold ES, Jahnsen FL (2026)
    Ultra long-lived plasma cells in the human small intestine produce microbiota-reactive IgA antibodies
    Benef Microbes, 1-13 (in press)
    DOI 10.1163/18762891-bja00120, PubMed 42128407
40. Pongdee T, Castells M, Akin C, Dybedal I, Gotlib J, Panse JP, Alvarez-Twose I, Cabeza CM, Cerquozzi S, Vadas P, Swarup V, Vachhani P, Wortmann F, Yi CA, Bidollari I, Newberry K, Shaheen D, Hartmann K (2026)
    Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis
    World Allergy Organ J, 19 (4), 101352
    DOI 10.1016/j.waojou.2026.101352, PubMed 41867266
41. Rasmussen ASB, Rank CU, Christensen IJ, Weimann A, Hansen K, Thastrup M, Yang T, Lund TM, Wik HS, Vogt H, Norén-Nyström U, Vaitkeviciene G, Albertsen BK, Wehner PS, Als-Nielsen B, Andersen CL, Dalhoff K, Schmiegelow K (2026)
    Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications
    Cancer Chemother Pharmacol, 96 (1)
    DOI 10.1007/s00280-026-04914-9, PubMed 42315664
42. Reikvam H, Vardanyan S, Tvedt THA (2026)
    Early pharmacological intervention in acute promyelocytic leukemia: can we still improve outcomes?
    Expert Rev Hematol, 19 (7), 681-684
    DOI 10.1080/17474086.2026.2672111, PubMed 42095625
43. Renders S, Ngoya M, de Leval L, Finel H, Khvedelidze I, Pocock R, Ram R, Gedde-Dahl T, Serroukh Y, Bug G, Kröger N, Nagler A, Pabst T, Rabitsch W, Yakoub-Agha I, Eder M, Ratip S, Scheid C, Pérez-Simón JA, Wagner-Drouet EM, Sureda A, Schmitz N, Glass B, Bazarbachi A, Dreger P (2026)
    Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
    Leukemia, 40 (8), 1802-1806
    DOI 10.1038/s41375-026-02993-4, PubMed 42297918
44. Rinaldetti S, Chepeleva M, Hedblom A, Sticht C, Muciek M, Panayiotidis P, Richter J, Olsson-Strömberg U, Nowak D, Nowak V, Ljungman P, von Bubnoff N, Lotfi K, Stenke L, Brümmendorf TH, Hjorth-Hansen H, Gedde-Dahl T, Majeed W, Burchert A, Nazarov PV, Felde E, Tarnopolscaia I, Hoelting C, Fabarius A, Hofmann WK et al. (2026)
    Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study
    Leukemia, 40 (8), 1698-1707
    DOI 10.1038/s41375-026-03001-5, PubMed 42315627
45. Robin M, Gras L, Koster L, Ayuk F, Potter V, Schroeder T, Friis LS, de Latour RP, Franke GN, Blau IW, Mielke S, Sockel K, Devillier R, Maertens J, Marková MŠ, Stelljes M, Gedde-Dahl T, Kinsella F, Yakoub-Agha I, Ure UB, Isidori A, Drozd-Sokolowska J, Raj K, Onida F, Gurnari C et al. (2026)
    Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT
    Am J Hematol, 101 (8), 2088-2094
    DOI 10.1002/ajh.70386, PubMed 42210450
46. Schjesvold F, Spencer A, Cohen YC, Ocio EM, Lopez-Pardo J, Cafro AM, Callander NS, Kaufman JL, Mohan M, Wermke M, Doki N, Kan R, Milanez-Almeida P, Stein A, Trabucco G, Ye S, Kulec K, Sechaud R, Banerjee S, Zhong H, Lai C, Rauch PJ, Raab MS (2026)
    Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma
    Cancer, 132 (7), e70341
    DOI 10.1002/cncr.70341, PubMed 41880322
47. Shapiro AD, Nakar C, Parker JM, Thibaudeau K, Crea R, Sandset PM (2026)
    Plain language summary: a phase 2/3 study of plasminogen, human-tvmh for the treatment of children and adults with type 1 plasminogen deficiency
    Expert Rev Hematol, 19 (7), 669-680
    DOI 10.1080/17474086.2026.2678346, PubMed 42226455
48. Siebenhaar F, Broesby-Olsen S, Castells M, George TI, Livideanu CB, Álvarez-Twose I, Panse J, Barete S, Reiter A, Dybedal I, Akin C, Van Daele P, Radia DH, Cerquozzi S, Ustun C, Sabato V, Gotlib J, Rafferty M, DeAngelo DJ, Schafhausen P, Ungerstedt J, Ogbogu PU, Florell S, Wada DA, Rets A et al. (2026)
    Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study
    J Am Acad Dermatol, 94 (6), 1705-1713
    DOI 10.1016/j.jaad.2026.02.025, PubMed 41690487
49. Song P, Jiang D, Zhou J, Zhu Y, Manaf RA, Bojude DA, Agbre-Yace ML, Ali S, Allen O, Anyasodor AE, Aranda Z, Bahattab A, Bodomo A, Borrescio-Higa F, Buchtova M, Buljan N, Deshmukh V, Díaz-Castro L, Cheema S, Ekezie W, Ganasegeran K, Ganesan B, Glasnović A, Graham CJ, Htay MNN et al. (2026)
    Research priorities for data science and artificial intelligence in global health: an international consensus exercise
    Lancet Glob Health, 14 (3), e455-e465
    DOI 10.1016/S2214-109X(25)00473-5, PubMed 41713447
50. Spyridonidis A, Ferhat AT, Galimard JE, Schroeder T, Peffault de Latour R, Kröger N, Blaise D, Stelljes M, Eder M, Gedde-Dahl T, Blau IW, Yakoub-Agha I, Forcade E, Huynh A, Kinsella F, Labussière-Wallet H, Passweg J, Zeiser R, Houhou M, Savani B, Shouval R, Versluis J, Mohty M, Ciceri F, Ruggeri A (2026)
    A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-026-02950-w, PubMed 42393231
51. Suul SG, Kvam AK, Hestdalen ML, Randen U, Midtvedt Ø, Tjønnfjord GE (2026)
    Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed Therapy
    Am J Case Rep, 27, e950857
    DOI 10.12659/AJCR.950857, PubMed 41792990
52. Tjønnfjord GE, Osnes LTN, Spetalen S, Haave U, Popperud TH, Maniaol AH, Østlie I, Bajelan L, Hamnvik LHD, Marvyin K, Miskovic D, Tjønnfjord EB, Winje K, Moksnes M, Tvedt THA, Kvam AK, Malecka A (2026)
    Anti-MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B-Cell Population
    J Immunol Res, 2026 (1), e1959235
    DOI 10.1155/jimr/1959235, PubMed 42396941
53. Troensegaard H, Veierød MB, Westerberg AC, Carlsen MH, Tonstad S, Bjørnerem Å, Holven KB, Retterstøl K, Iversen PO, Khoury J (2026)
    No Differences in Blood Pressure or Anthropometric Measures in 3-Year-Old Children After a Randomized Mediterranean Dietary Intervention During Pregnancy in Norway
    Acta Paediatr (in press)
    DOI 10.1111/apa.70721, PubMed 42573466
54. Trydal T, Tjønnfjord GE (2026)
    Clinical Reasoning as the Guiding Framework in Medical Biochemical Test Reporting
    Diagnostics (Basel), 16 (15)
    DOI 10.3390/diagnostics16152475, PubMed 42587711
55. Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjønnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahévas M, Michel M, Bussel J, Kuter DJ, Anderson Tvedt TH, Ghanima W (2026)
    Safety and efficacy of daratumumab in immune thrombocytopenia
    Blood Adv, 10 (1), 143-154
    DOI 10.1182/bloodadvances.2025017279, PubMed 40763272
56. Tsykunova G, Kristiansen EB, Tvedt THA, Frederiksen H, Christiansen CF, Linder M, Bahmanyar S, Ghanima W (2026)
    Factors associated with response to rituximab in patients with immune thrombocytopenia
    Hemasphere, 10 (5), e70373
    DOI 10.1002/hem3.70373, PubMed 42058647
57. Van Daele W, Tito Tadeo RY, Perera J, Tshokey T, Iversen PO, Jayasinghe S, Raffaetà R, Wangmo N, Fjeld HE, R SC, Thoradeniya T, Raes J (2026)
    Toward ethical human microbiome research: improving health through radical interdisciplinary and intercultural co-laboration
    Microbiome, 14 (1)
    DOI 10.1186/s40168-026-02340-w, PubMed 41947255
58. van de Donk NWCJ, Schjesvold F, van der Holt B, Minnema MC, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Bringhen S, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M et al. (2026)
    Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
    Blood Cancer J, 16 (1)
    DOI 10.1038/s41408-026-01549-0, PubMed 42337226
59. Vaz F, Lindeman I, Hoffmann HH, Skagen C, Steffensen AK, Bjørnholt JV, Tjønnfjord GE, Lundin KEA, Sollid LM, Iversen R (2026)
    Distinct systemic and gut IgA responses to bacteria of the human upper gastrointestinal tract
    Cell Rep, 45 (8), 117721 (in press)
    DOI 10.1016/j.celrep.2026.117721, PubMed 42497062

Publications 2025

1. Acs K, Miettinen JJ, Sergeev P, Heckel T, Diao Y, Witt-Mulder K, Thureson M, Bischler T, Huppunen ME, Suvela M, Obermüller J, Munawar U, Slipicevic A, Bargou RC, Lehmann F, Gelius SS, Norin S, Schjesvold F, Sonneveld P, Stühmer T, Heckman CA (2025)
   Efficacy of melflufen in multiple myeloma with mutated or deleted TP53
   Exp Hematol Oncol, 14 (1), 138
   DOI 10.1186/s40164-025-00729-1, PubMed 41437395
2. Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J et al. (2025)
   Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
   J Clin Oncol, 43 (22), 2527-2537
   DOI 10.1200/JCO-25-00744, PubMed 40459178
3. Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J et al. (2025)
   Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
   J Clin Oncol, 43 (27), 3056
   DOI 10.1200/JCO-25-01767, PubMed 40779730
4. Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I (2025)
   Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera
   Cancer Genomics Proteomics, 22 (1), 24-33
   DOI 10.21873/cgp.20483, PubMed 39730178
5. Andresen MS, Mowinckel MC, Skarpen E, Andersen E, Sandset PM, Chollet ME, Stavik B (2025)
   Identification and evaluation of Pharmacological enhancers of the factor VII p.Q160R variant
   Sci Rep, 15 (1), 14315
   DOI 10.1038/s41598-025-98689-3, PubMed 40274887
6. Askeland FB, Bugge VH, Rasmussen AM, Lysén A, Haukås E, Moksnes M, Eilertsen AL, Tsykunova G, Eiken BD, Leknes NM, Rolke J, Stavseth V, Samstad E, Hallstensen RF, Szatkowski D, Hansen AA, Nilsen AS, Slørdahl TS, Abdollahi P, Schjesvold F (2025)
   Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma
   Blood Cancer J, 15 (1), 214
   DOI 10.1038/s41408-025-01407-5, PubMed 41429779
7. Askeland FB, Haukås E, Slørdahl TS, Klostergaard A, Alexandersen T, Lysén A, Abdollahi P, Nielsen LK, Hermansen E, Schjesvold F (2025)
   Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial
   Lancet Haematol, 12 (2), e120-e127
   DOI 10.1016/S2352-3026(24)00347-8, PubMed 39909655
8. Astermark J, Ranta S, Myrin-Westesson L, Hoffmann M, Quere S, Sanchez AYC, Robson S, Czirok T, Lassila R, Holme PA (2025)
   Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study
   Haemophilia, 31 (6), 1271-1282
   DOI 10.1111/hae.70121, PubMed 40898745
9. Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R (2025)
   Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
   Eur Heart J Cardiovasc Pharmacother, 11 (3), 275-289
   DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
10. Bazarbachi A, Galimard JE, Dalle IA, Socié G, Versluis J, Wu D, Eder M, Labussière-Wallet H, Yakoub-Agha I, Maertens J, Forcade E, Gedde-Dahl T, Choi G, Castilla-Llorente C, Baron F, Brissot E, Esteve J, Nagler A, Mohty M, Ciceri F (2025)
    Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP
    Am J Hematol, 100 (8), 1374-1386
    DOI 10.1002/ajh.27726, PubMed 40445901
11. Befring AKC, Sandset PM (2025)
    [Unintended consequences of the new Health Research Act]
    Tidsskr Nor Laegeforen, 145 (15)
    DOI 10.4045/tidsskr.25.0653, PubMed 41410974
12. Bergland BS, Remberger M, Tjønnfjord GE, Vo CD, Myhre AE, Abrahamsen IW, Gedde-Dahl T, Tvedt THA (2025)
    Should a young matched unrelated donor be preferred over an older matched related donor in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome?
    Bone Marrow Transplant, 60 (7), 1062-1064
    DOI 10.1038/s41409-025-02579-1, PubMed 40251418
13. Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau C et al. (2025)
    European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
    Hemasphere, 9 (10), e70216
    DOI 10.1002/hem3.70216, PubMed 41089883
14. Brunetti M, Andersen K, Spetalen S, Tjønnfjord GE, Heim S, Micci F (2025)
    Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia
    Anticancer Res, 45 (3), 921-928
    DOI 10.21873/anticanres.17479, PubMed 40037847
15. Busterud K, Remberger M, Bentsen PT, Jerm MB, Gedde-Dahl T, Olsnes AM, Tjønnfjord GE (2025)
    Allogeneic stem cell transplantation for acute myeloid leukaemia 2005-22
    Tidsskr Nor Laegeforen, 145 (12)
    DOI 10.4045/tidsskr.25.0001, PubMed 41097944
16. Costa LJ, Banerjee R, Mian H, Weisel K, Bal S, Derman BA, Htut MM, Nagarajan C, Rodriguez C, Richter J, Frigault MJ, Ye JC, van de Donk NWCJ, Voorhees PM, Puliafito B, Bahlis N, Popat R, Chng WJ, Ho PJ, Kaur G, Kapoor P, Du J, Schjesvold F, Berdeja J, Einsele H et al. (2025)
    International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
    Leukemia, 39 (3), 543-554
    DOI 10.1038/s41375-024-02482-6, PubMed 39870767
17. Desai N, Al-Shaibani E, Alfaro-Moya T, Law AD, Lam W, Remberger M, Pasic I, Novitzky-Basso I, Viswabandya A, Kim DD, Kumar R, Lipton JH, Mattsson J, Michelis FV (2025)
    Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation
    Br J Haematol, 207 (3), 938-945
    DOI 10.1111/bjh.70006, PubMed 40682490
18. Dimopoulos MA, Terpos E, Boccadoro M, Moreau P, Mateos MV, Zweegman S, Cook G, Engelhardt M, Delforge M, Hajek R, Schjesvold F, Gay F, Manier S, Weisel KC, Kaiser M, van de Donk NWCJ, Zamagni E, Rodriguez-Otero P, Perrot A, Driessen C, Bila J, Laane E, Dytfeld D, Touzeau C, Beksac M et al. (2025)
    EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
    Nat Rev Clin Oncol, 22 (9), 680-700
    DOI 10.1038/s41571-025-01041-x, PubMed 40624367
19. Dybedal I, Iversen N, Jacobsen AF, Bjørge L, Chaireti R, Henriksson CE, Schultz NH, Hvas AM, Sandset PM, Weedon-Fekjær H, Bremme K, Abildgaard U (2025)
    Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study
    J Thromb Haemost, 23 (9), 2807-2818
    DOI 10.1016/j.jtha.2025.03.001, PubMed 40086756
20. Ernst MPT, Versluis J, Valk PJM, Bierings M, Tamminga RYJ, Hooimeijer LH, Döhner K, Gresele P, Tawana K, Langemeijer SMC, Van der Reijden BA, Podgornik H, Sever M, Tvedt THA, Vulliamy T, Fitzgibbon J, Dokal I, Baliakas P, Bastida JM, Pohlkamp C, Haferlach T, Larcher L, Soulier J, Schutgens REG, Freson K et al. (2025)
    Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
    Hemasphere, 9 (1), e70057
    DOI 10.1002/hem3.70057, PubMed 39822584
21. Esteve J, Nagler A, Labopin M, Versluis J, Sanz J, Gedde-Dahl T, Burns D, Roeven M, Labussière-Wallet H, von dem Borne P, van Gorkom G, Contentin N, Neubauer A, Wagner-Drouet EM, Kröger N, Mohty M, Ciceri F (2025)
    Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
    Am J Hematol, 100 (6), 954-962
    DOI 10.1002/ajh.27647, PubMed 40062532
22. Frøen HM, Brodtkorb M, Holte H, Kolstad A, Myhre AE, Remberger M, Tjønnfjord GE, Gedde-Dahl T (2025)
    Allogeneic stem cell transplantation for patients with lymphoma 2011-21
    Tidsskr Nor Laegeforen, 145 (3)
    DOI 10.4045/tidsskr.24.0443, PubMed 40042014
23. Gudmundstuen AM, Iversen PO, Pesonen M, Hjermstad MJ, Bye A, Tjønnfjord GE, Skaarud KJ (2025)
    Comparing indirect calorimetry and predictive equations for energy expenditure - 1 year follow-up of adult hematopoietic stem cell transplanted recipients
    Clin Nutr ESPEN, 70, 218-226
    DOI 10.1016/j.clnesp.2025.09.027, PubMed 41038512
24. Gulati G, Hedayati E, Lenartova A, Pareek M, Atar D (2025)
    Cardio-Oncology: Risk Stratification, Guideline Recommendations, and Exemplifications in Breast Cancer and Chronic Lymphatic Leukemia - An ad hoc Expert Opinion
    Cardiology, 151 (2), 141-150
    DOI 10.1159/000549958, PubMed 41777165
25. Gundesen MT, Schjesvold F, Lund T (2025)
    Treatment of myeloma bone disease: When, how often, and for how long?
    J Bone Oncol, 52, 100680
    DOI 10.1016/j.jbo.2025.100680, PubMed 40242221
26. Gurnari C, Robin M, Adès L, Aljurf M, Almeida A, Duarte FB, Bernard E, Cutler C, Della Porta MG, De Witte T, DeZern A, Drozd-Sokolowska J, Duncavage E, Fenaux P, Gagelmann N, Garcia-Manero G, Haferlach C, Haferlach T, Hasserjian R, Hellström-Lindberg E, Jacoby M, Kulasekararaj A, Lindsley RC, Maciejewski JP, Makishima H et al. (2025)
    Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
    Blood, 145 (18), 1987-2001
    DOI 10.1182/blood.2024025131, PubMed 39970324
27. Güven M, Peczynski C, Boreland W, Blaise D, Peffault de Latour R, Yakoub-Agha I, Gedde-Dahl T, Salmenniemi U, Forcade E, Passweg J, Chevallier P, Sandrine L, Mielke S, Broers A, Ceballos P, Byrne J, Castilla-Llorente C, Maertens J, Huynh A, Cerretti R, Bulabois CE, van Gorkom G, Crawley C, Graham C, Mussetti A et al. (2025)
    The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
    Bone Marrow Transplant, 60 (7), 956-963
    DOI 10.1038/s41409-025-02580-8, PubMed 40246943
28. Halstensen TD, Hardeland C, Ghanima W, Grøndahl VA, Hubin A, Jørgensen CT, de Wit K, Tavoly M (2025)
    External validation of the DAYS score for suspected deep vein thrombosis
    Res Pract Thromb Haemost, 9 (4), 102885
    DOI 10.1016/j.rpth.2025.102885, PubMed 40599363
29. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Gleditsch J, Tavoly M, Stavem K, Steine K, Atar D, Dahm AEA, Klok FA, Johannessen HH (2025)
    Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolism
    Res Pract Thromb Haemost, 9 (2), 102736
    DOI 10.1016/j.rpth.2025.102736, PubMed 40242191
30. Henoun Loukili N, Gras L, Koster L, Blaise D, Gedde-Dahl T, Maertens J, Friis LS, Mielke S, Chevallier P, Passweg JR, Byrne JL, Salmenniemi U, Ceballos P, Cornillon J, Sica S, Onida F, Scheid C, Gurnari C, Drozd-Sokolowska J, Raj K, Robin M, McLornan DP, Yakoub-Agha I (2025)
    Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
    Bone Marrow Transplant, 60 (11), 1487-1495
    DOI 10.1038/s41409-025-02682-3, PubMed 40883614
31. Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS (2025)
    Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
    Cell Death Dis, 16 (1), 555
    DOI 10.1038/s41419-025-07884-7, PubMed 40701968
32. Hjertholm KG, Iversen PO, Holmboe-Ottesen G, Jepsen R (2025)
    Risk factors for undernutrition and poor growth during the first 6 months of life in sub-Saharan Africa: A scoping review
    Clin Nutr ESPEN, 68, 309-318
    DOI 10.1016/j.clnesp.2025.05.019, PubMed 40383255
33. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2025)
    Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study
    Haemophilia (in press)
    DOI 10.1111/hae.70099, PubMed 40838268
34. Holstein SA, Atrash S, Mian H, Dimopoulos MA, Schjesvold F, Popat R, Shah N, Gatt ME, Gocke CB, Frenzel L, Touzeau C, Beksac M, Manier S, Magen H, Travis P, Nadeem O, Suryanarayan K, Li C, Li S, Nelson A, Cherepanov D, Parot X, Vogl DT (2025)
    A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
    Blood, 146 (9), 1051-1064
    DOI 10.1182/blood.2024027873, PubMed 40279508
35. Hvitmyhr C, Enga KF, Øverbø J, Midgard H, Reikvam DH (2025)
    A man in his 60s with immunodeficiency and hepatitis
    Tidsskr Nor Laegeforen, 145 (2)
    DOI 10.4045/tidsskr.25.0487, PubMed 41670322
36. Iacobelli S, Schönland S, Koster L, Blaise D, Nicholson E, Broers AEC, Chevallier P, Reményi P, Folber F, Gribben JG, Nur E, Rabin N, Collin M, Gedde-Dahl T, Bailey K, Ferguson P, Stelljes M, Bloor A, Beksac M, Drozd-Sokolowska J, Raj K, Hayden PJ, Yakoub-Agha I, McLornan DP, Kröger N (2025)
    Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant, 60 (10), 1361-1368
    DOI 10.1038/s41409-025-02675-2, PubMed 40739129
37. Iversen PO, Gedde-Dahl T, Tjønnfjord GE, Ali MM (2025)
    Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease
    Br J Haematol, 207 (5), 2183-2186
    DOI 10.1111/bjh.70119, PubMed 40875520
38. Klevmoen M, Mulder JWCM, Bogsrud MP, Retterstøl K, Vesterbekkmo EK, Pedersen EKR, Freiberger T, Vrablik M, Vaclova M, Hovland A, Vethe NT, Brekke HK, Iversen PO, Veierød M, Roeters van Lennep J, Holven KB (2025)
    Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study
    BMJ Open, 15 (4), e092208
    DOI 10.1136/bmjopen-2024-092208, PubMed 40288796
39. Kopland M, Ottersen VS, Dahle DO, Gedde-Dahl T, Dalgaard J (2025)
    [A man in his 50s with acute renal failure, anemia, and thrombocytopenia]
    Tidsskr Nor Laegeforen, 145 (1)
    DOI 10.4045/tidsskr.24.0231, PubMed 39835860
40. Mishra V, Gedde-Dahl T, Remberger M, Solvang G, Selvaag KL, Fosseng A, Abrahamsen IW, Myhre AE, Hagen TP, Tjønnfjord GE (2025)
    Hospital at Home Following Allogeneic Hematopoietic Stem Cell Transplantation: An Economic Analysis
    Healthcare (Basel), 13 (14)
    DOI 10.3390/healthcare13141648, PubMed 40724674
41. Moore KLF, Rognvaldsson S, Szabo AG, Vaitekėnaitė V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH, Study Group NM (2025)
    Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group
    Haematologica, 111 (2), 693-697
    DOI 10.3324/haematol.2025.287344, PubMed 40905090
42. Nagler A, Ferhat AT, Kayser S, Eder M, Kröger N, Stelljes M, Maertens J, Peffault de Latour R, Blau IW, Schroeder T, Reményi P, Gedde-Dahl T, Bug G, Blaise D, Bazarbachi A, Esteve J, Mohty M, Ciceri F (2025)
    Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
    Bone Marrow Transplant, 60 (9), 1218-1227
    DOI 10.1038/s41409-025-02620-3, PubMed 40442255
43. Nagler A, Kayser S, Ferhat AT, Kröger N, Eder M, Socié G, Blaise D, Schroeder T, Labussière-Wallet H, Maertens J, Busca A, Forcade E, Gedde-Dahl T, Rambaldi A, Bulabois CE, Bug G, Bazarbachi A, Brissot E, Savani B, Mohty M, Ciceri F (2025)
    Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT
    Am J Hematol, 101 (2), 281-290
    DOI 10.1002/ajh.70164, PubMed 41351865
44. Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Osnes L, Stokke C, Connelly JP, Revheim MR, Schjesvold F (2025)
    Progression-Free and Overall Survival After KRd Consolidation in FDG PET/CT Positive Patients After ASCT: A Phase II Study (CONPET)
    Clin Lymphoma Myeloma Leuk, 26 (3), e335-e343.e2
    DOI 10.1016/j.clml.2025.10.020, PubMed 41314938
45. Pedersen TH, Tjønnfjord E, Korkama ES, Vikman M, Ahmadi A, Overgaard UM, Kjellander C (2025)
    The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries
    Ann Hematol, 104 (8), 4277-4283
    DOI 10.1007/s00277-025-06450-7, PubMed 40632273
46. Podgorica M, Drivet E, Vestbøstad J, Kvam AK, Wik HS, Munthe L, Schjerven H (2025)
    Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL)
    Leuk Lymphoma, 66 (12), 2311-2315
    DOI 10.1080/10428194.2025.2536125, PubMed 40728071
47. Posadas-Cantera S, Mitsuiki N, Emmerich F, Patiño V, Lorenz HM, Neth O, Dybedal I, Taskén K, Schäffer AA, Grimbacher B, Gámez-Díaz L (2025)
    The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency
    Front Immunol, 15, 1447995
    DOI 10.3389/fimmu.2024.1447995, PubMed 39835139
48. Prata PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, Drexler B, Tjon JM, Vaht K, Aljurf M, Chevallier P, Gedde-Dahl T, Kaare A, Salmenniemi U, Schroeder T, Byrne J, Cornillon J, Barraco F, Maertens J, Tholouli E, Platzbecker U, Kröger N, Blaise D, Sica S, Zeiser R, Risitano AM, De Latour RP et al. (2025)
    Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report
    Haematologica, 111 (1), 168-176
    DOI 10.3324/haematol.2024.287205, PubMed 40605711
49. Quist-Paulsen P, Horvei L, Dalgaard J, Moksnes M, Eilertsen AL, Paulson M, Azrakhsh NA, Majeed W, Wik HS (2025)
    Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol-A prospective study
    Br J Haematol, 207 (6), 2434-2440
    DOI 10.1111/bjh.70159, PubMed 40947499
50. Rampotas A, Aspa-Cilleruelo JM, Koster L, Avenoso D, Passweg J, Sala E, Robin M, Myhre AE, de Witte M, Nur E, Chevallier P, Schroeder T, Srour M, Chiusolo P, Salmenniemi U, Verbeek M, Finazzi MC, Castilla-Llorente C, Rubio MT, Sobieralski P, Sockel K, Alabdulkarim A, Drozd-Sokolowska J, Raj K, Battipaglia G et al. (2025)
    A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm
    Bone Marrow Transplant, 61 (3), 333-340
    DOI 10.1038/s41409-025-02780-2, PubMed 41444442
51. Rasmussen B, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Cavalier L, Ebeling F, Olsnes AM, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E, Schlegelberger B, Göhring G (2025)
    Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide
    Genes Chromosomes Cancer, 64 (2), e70029
    DOI 10.1002/gcc.70029, PubMed 39921387
52. Richardson P, Beksaç M, Oriol A, Lindsay J, Schjesvold F, Galli M, Yağcı M, Larocca A, Weisel K, Yu X, Donahue C, Acosta J, Peluso T, Dimopoulos M (2025)
    Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial
    Eur J Haematol, 114 (5), 822-831
    DOI 10.1111/ejh.14365, PubMed 39777934
53. Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Anderson KC (2025)
    A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma
    Future Oncol, 21 (6), 653-663
    DOI 10.1080/14796694.2025.2449781, PubMed 39851267
54. Richter J, Nooka A, Rodríguez-Otero P, Schjesvold F, Katodritou E, Combe E, Scott M, Cooper L, Sly I, Ballew N, Bitetti J, Boytsov N, Purser M, McNamara S (2025)
    Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis
    Am J Hematol, 100 (6), 998-1009
    DOI 10.1002/ajh.27661, PubMed 40143674
55. Rodriguez-Otero P, Voorhees PM, Boccadoro M, Laubach J, Einsele H, Sborov DW, Dimopoulos MA, Broijl A, Mina R, Spencer A, Schjesvold F, Silbermann R, Gay F, Costa LJ, Perrot A, Liu Y, Wang J, Sitthi-Amorn A, Carson R, Cortoos A, Usmani SZ, Richardson PG, Moreau P, Sonneveld P, Kaufman JL (2025)
    Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
    Clin Lymphoma Myeloma Leuk, 25 (10), 746-758.e6
    DOI 10.1016/j.clml.2025.04.007, PubMed 40360369
56. Roman G, Lauritzen KH, Harrison SP, Bhattacharya A, Andresen MS, Mowinckel MC, Smolkova B, Henriksson CE, Glosli H, Iversen N, Thiede B, Sullivan GJ, Almaas R, Sandset PM, Stavik B, Chollet ME (2025)
    Ex vivo correction of severe coagulation Factor VII deficiency in patient-derived 3D liver organoids
    Haematologica, 111 (3), 941-954
    DOI 10.3324/haematol.2025.288046, PubMed 41063698
57. Ru Y, Chen J, Ferhat AT, Labussière-Wallet H, Gedde-Dahl T, Kröger N, Socié G, Yakoub-Agha I, Eder M, Mielke S, Wu D, Mohty M, Ciceri F, Gorin NC (2025)
    Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 100 (12), 2220-2229
    DOI 10.1002/ajh.70069, PubMed 40927841
58. Rüfer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink JNG, Bonadonna P, Shoumariyeh K, Gulen T, Hartmann K, Sabato V, Angelova-Fischer I, Baffoe D, Christen D, Belloni Fortina A, Breynaert C, Brockow K, von Bubnoff N, Bumbea H, van Daele P, Doubek M, Dybedal I, Elena C, Fokoloros C, Górska A, Heizmann M et al. (2025)
    Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis
    Leukemia, 39 (3), 675-683
    DOI 10.1038/s41375-024-02504-3, PubMed 39815050
59. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2025)
    Correction: Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 39 (6), 1545
    DOI 10.1038/s41375-025-02516-7, PubMed 40374810
60. Seland M, Rognli S, Skaali T, Blomhoff R, Tjønnfjord GE, Eriksen AMA, Solvang G, Thorsen L (2025)
    Distress, problems and unmet rehabilitation needs after haematopoietic stem cell transplantation for haematologic malignancies: A cross-sectional study
    Eur J Oncol Nurs, 80, 103083
    DOI 10.1016/j.ejon.2025.103083, PubMed 41576829
61. Selvaag KL, Eriksen S, Nickelsen M, Solvang G, Vemøy K, Tjønnfjord GE, Lærum-Onsager E (2025)
    Allogeneic Haematopoietic Stem Cell Transplantation Recipients' Experiences of Outdoor Physical Activity: A Qualitative Study
    Scand J Caring Sci, 39 (1), e70016
    DOI 10.1111/scs.70016, PubMed 40075514
62. Singh PB, Singh SV, Iversen PO, Jensen JL (2025)
    Evaluation and management of chemosensory, trigeminal, and salivary dysfunctions in patients with post coronavirus disease
    Clin Nutr ESPEN, 70, 452-462
    DOI 10.1016/j.clnesp.2025.10.018, PubMed 41115655
63. Skøyeneie SCT, Wik HS, Tjønnfjord GE, Fauske L, Gedde-Dahl T, Myhre AEL (2025)
    Family Caregivers’ Experiences of Hospital at Home Following Allogeneic Haematopoietic Stem Cell Transplantation: A Qualitative Study
    European Journal of Cancer Care, 2025 (1), 7043910
    DOI 10.1155/ecc/7043910, PublikaID 544
64. Skaarud KJ, Gudmundstuen AM, Pesonen M, Hjermstad MJ, Iversen PO, Tjønnfjord GE (2025)
    The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
    Sci Rep, 15 (1), 1675
    DOI 10.1038/s41598-024-84805-2, PubMed 39799129
65. Slørdahl TS, Askeland FB, Hanssen MSS, Hov H, Sundt-Hansen SM, Lindahl S, Vethe NT, Hjorth-Hansen H, Fenstad MH, Waage A, Hjertner Ø, Schjesvold F, Sundan A (2025)
    Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
    EJHaem, 6 (1), e1091
    DOI 10.1002/jha2.1091, PubMed 39866949
66. Smit AJT, Van der Maas NG, Van der Holt B, Van Norden Y, Van Werkhoven E, Vangsted AJ, Ypma PF, Visser-Wisselaar HA, Troia R, Boccadoro M, Löwenberg B, Janssen JJWM, Ossenkoppele GJ, Schjesvold F, Sonneveld P, Zweegman S, Versluis J, Cornelissen JJ (2025)
    The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology
    Haematologica, 111 (3), 1105-1110
    DOI 10.3324/haematol.2025.288675, PubMed 41035401
67. Spencer A, Gavriatopoulou M, Coriu D, Lysén A, Gutiérrez NC, Escalante F, Eugenia Fantl DB, Hájek R, Seguro F, Kaur G, Bittencourt R, Kinda SB, Chu MP, Safah H, Martinez-Lopez J, de Queiroz Crusoé E, Cordeiro de Farias DL, Offidani M, Askari E, Sevindik ÖG, Maisnar V, Teng CL, Hughes O, Taylor R, Lehn K et al. (2025)
    Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
    Blood Adv, 9 (22), 5814-5827
    DOI 10.1182/bloodadvances.2025017214, PubMed 40829119
68. Svalastoga M, Larsen TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2025)
    Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
    Front Oncol, 15, 1520725
    DOI 10.3389/fonc.2025.1520725, PubMed 39931081
69. Teimori K, Larsen BS, Austli MB, Nilsson N, Tho I, Nezvalova-Henriksen K (2025)
    Strategies for Assessing Physical Compatibility of Calcium Folinate with Bicarbonate During Methotrexate Rescue Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia
    Pharmaceutics, 17 (9)
    DOI 10.3390/pharmaceutics17091155, PubMed 41012494
70. Thorsteinsdóttir S, Lemonakis K, Slørdahl TS, Rögnvaldsson S, Richardson AK, Hermansen E, Thorsen J, Schjesvold F, Moore KLF, Szabo AG, Andersen MK, Waage A, Blimark CH, Vangsted A, Nordic Myeloma Study Group (2025)
    Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group
    Br J Haematol, 207 (4), 1638-1642
    DOI 10.1111/bjh.70030, PubMed 41070698
71. Tinglum Skøyeneie SC, Wik HS, Tjønnfjord GE, Fauske L, Gedde-Dahl T, Solvang G, Myhre AE (2025)
    Perceptions of safety in hospital at home following allogeneic haematopoietic stem cell transplantation: A qualitative study
    Eur J Oncol Nurs, 80, 103044
    DOI 10.1016/j.ejon.2025.103044, PubMed 41325692
72. Tjønnfjord EB, Tveten K, Spetalen S, Tjønnfjord GE (2025)
    ANKRD26 Gene Mutation and Thrombocytopenia-Is the Risk of Malignancy Dependent on the Mutation Variant?
    Hematol Rep, 17 (4)
    DOI 10.3390/hematolrep17040037, PubMed 40863182
73. Tvedt THA, Qvigstad C, Nezvalova-Henriksen K, Bergland BS, Bruserud Ø, Reikvam H (2025)
    Three-Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients
    Eur J Haematol, 115 (6), 565-573
    DOI 10.1111/ejh.70011, PubMed 40840957
74. van de Donk NWCJ, Moreau P, San-Miguel JF, Mateos MV, Dimopoulos MA, Zweegman S, Gay F, Engelhardt M, Mina R, Zamagni E, Delforge M, Beksac M, Spencer A, Schjesvold F, Driessen C, Kaiser M, Perrot A, Wäsch R, Korst CL, Broijl A, Touzeau C, Manier S, Hajek R, Ludwig H, Fernandez de Larrea C et al. (2025)
    Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
    Lancet Haematol, 12 (8), e635-e649
    DOI 10.1016/S2352-3026(25)00117-6, PubMed 40580975
75. van de Donk NWCJ, Moreau P, San-Miguel JF, Mateos MV, Dimopoulos MA, Zweegman S, Gay F, Engelhardt M, Mina R, Zamagni E, Delforge M, Beksac M, Spencer A, Schjesvold F, Driessen C, Kaiser M, Perrot A, Wäsch R, Korst CLBM, Broijl A, Touzeau C, Manier S, Hajek R, Bila J, Seval GC et al. (2025)
    Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
    Hemasphere, 9 (11), e70260
    DOI 10.1002/hem3.70260, PubMed 41306326
76. Villalba M, Ferhat AT, Gedde-Dahl T, Socie G, Huynh A, Blau IW, Yakoub-Agha I, Blaise D, Eder M, Forcade E, Fanin R, Passweg J, Crawley C, Stelljes M, Stölzel F, Kroeger N, Sengeloev H, Ceballos P, Labussiere-Wallet H, Poiré X, Esteve J, Savani B, Nagler A, Piemontese S, Sanz J et al. (2025)
    Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party
    Bone Marrow Transplant, 61 (2), 187-196
    DOI 10.1038/s41409-025-02751-7, PubMed 41318843
77. Vonk CM, Grob T, Rijken M, Kavelaars FG, Konijnenburg JML, Ossenkoppele GJ, Manz MG, Havelange V, Fløisand Y, Löwenberg B, Valk PJM (2025)
    Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML
    Blood Adv, 9 (5), 1069-1077
    DOI 10.1182/bloodadvances.2024014490, PubMed 39637308
78. Vrotniakaite-Bajerciene K, Mallick R, Takada T, Kraaijpoel N, van Smeden M, Moons KGM, Kline JA, Huisman MV, Martens E, Righini M, van Es N, Klok FA, Büller HR, Perrier A, de Wit K, Wells PS, Galipienzo J, Ghanima W, Roy PM, Carrier M, Geersing GJ, Le Gal G (2025)
    Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis
    J Thromb Haemost, 24 (3), 971-984
    DOI 10.1016/j.jtha.2025.10.035, PubMed 41354153
79. Vydra J, Ferhat AT, Kröger N, Gedde-Dahl T, Eder M, Schroeder T, Salmenniemi U, de Latour RP, Passweg J, Yakoub-Agha I, Rambaldi A, Zeiser R, Stelljes M, Carlson K, Castilla-Llorente C, Spyridonidis A, Savani B, Ciceri F, Mohty M (2025)
    Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
    Bone Marrow Transplant, 61 (2), 206-210
    DOI 10.1038/s41409-025-02766-0, PubMed 41339490
80. Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA (2025)
    Targeting proteostasis in multiple myeloma through inhibition of LTK
    Leukemia, 39 (9), 2237-2245
    DOI 10.1038/s41375-025-02682-8, PubMed 40634511
81. Yang T, Rasmussen ASB, Weimann A, Thastrup M, Rank CU, Als-Nielsen B, Malmros J, Wik HS, Lohi O, Overgaard U, Johannsdottir IMR, Vaitkeviciene G, Dalhoff K, Schmiegelow K, Lund TM (2025)
    Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients
    Target Oncol, 20 (5), 871-886
    DOI 10.1007/s11523-025-01172-2, PubMed 40920292
82. Ye Y, Labopin M, Yakoub-Agha I, Socié G, Blaise D, Gedde-Dahl T, Blau IW, Raiola AM, Byrne J, Daguindau E, Labussière-Wallet H, Huynh A, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Mohty M, Huang H, Ciceri F (2025)
    Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 100 (10), 1760-1771
    DOI 10.1002/ajh.70008, PubMed 40650544

Publications 2024

1. Abdollahi P, Norseth HM, Schjesvold F (2024)
   Advances and challenges in anti-cancer vaccines for multiple myeloma
   Front Immunol, 15, 1411352
   DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
2. Al Hamed R, Labopin M, Wu D, Gedde-Dahl T, Aljurf M, Forcade E, Salmenniemi U, Passweg J, Maertens J, Pabst T, Versluis J, Itäla-Remes M, Huang XJ, Van Gorkom G, Schroeder T, Sanz J, Blaise D, Reményi P, Schanz U, Esteve J, Gorin NC, Ciceri F, Mohty M (2024)
   Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
   Bone Marrow Transplant, 59 (10), 1458-1465
   DOI 10.1038/s41409-024-02373-5, PubMed 39095548
3. Andersen K, Tjønnfjord GE, Ramslien LF, Panagopoulos I (2024)
   RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia
   Genes Chromosomes Cancer, 63 (9), e23272
   DOI 10.1002/gcc.23272, PubMed 39324493
4. Arrieta-Bolaños E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kröger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poiré X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A et al. (2024)
   Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
   J Clin Oncol, 42 (28), 3287-3299
   DOI 10.1200/JCO.24.00582, PubMed 39167735
5. Arrieta-Bolaños E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kröger N, Yakoub-Agha I, Huynh A, Crawley C, Deconinck E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K (2024)
   Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
   Blood, 144 (16), 1747-1751
   DOI 10.1182/blood.2024024351, PubMed 39102621
6. Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE (2024)
   Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
   Clin Lymphoma Myeloma Leuk, 25 (3), e127-e130
   DOI 10.1016/j.clml.2024.10.005, PubMed 39500643
7. Baliakas P, Tesi B, Cammenga J, Stray-Pedersen A, Jahnukainen K, Andersen MK, Ågerstam H, Creignou M, Dybedal I, Raaschou-Jensen K, Grønbæk K, Kilpivaara O, Lindberg EH, Wartiovaara-Kautto U (2024)
   How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
   Hemasphere, 8 (8), e145
   DOI 10.1002/hem3.145, PubMed 39139355
8. Berentsen S, Vos JMI, Malecka A, Tjønnfjord GE, D'Sa S (2024)
   The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms
   Expert Rev Hematol, 17 (8), 479-492
   DOI 10.1080/17474086.2024.2372333, PubMed 38938203
9. Brune M, Kiss T, Anderson H, Nicklasson M, Delage R, Finke J, Gedde-Dahl T, Hébert J, Höglund M, Kaare A, Lazarevic V, Möllgård L, Remes K, Ritchie D, Spyridonidis A, Sabloff M, Spearing R, Wallhult E, Ljungman P (2024)
   Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
   Bone Marrow Transplant, 59 (12), 1676-1682
   DOI 10.1038/s41409-024-02408-x, PubMed 39223244
10. Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
    NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
    Front Oncol, 14, 1371980
    DOI 10.3389/fonc.2024.1371980, PubMed 38571499
11. Brunetti M, Andersen K, Trøen G, Micci F, Spetalen S, Lenartova A, Tandsæther MR, Panagopoulos I (2024)
    Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)
    Front Oncol, 14, 1428984
    DOI 10.3389/fonc.2024.1428984, PubMed 39391249
12. Chalandon Y, Eikema DJ, Moiseev I, Ciceri F, Koster L, Vydra J, Passweg J, Rovira M, Ozcelik T, Gedde-Dahl T, Kröger N, Potter V, Yakoub-Agha I, Rambaldi A, Itälä-Remes M, Tanase A, Onida F, Gurnari C, Scheid C, Drozd-Sokolowska J, Raj K, McLornan DP, Robin M (2024)
    Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
    Blood Adv, 8 (18), 4792-4802
    DOI 10.1182/bloodadvances.2024013468, PubMed 39008719
13. Christiansen CF, Risbo N, Ghanima W, Linder M, Bahmanyar S, Seesaghur A, Clouser M, Nørgaard M, Sørensen HT (2024)
    Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
    Br J Haematol, 205 (4), 1497-1507
    DOI 10.1111/bjh.19688, PubMed 39102877
14. Cimini LA, Luijten D, Barco S, Ghanima W, Jervan Ø, Kahn SR, Konstantinides S, Lachant D, Nakano Y, Ninaber M, van Es J, van Mens T, Vonk Noordegraaf A, Becattini C, Klok FA (2024)
    Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis
    ERJ Open Res, 10 (4)
    DOI 10.1183/23120541.01010-2023, PubMed 39076522
15. Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK (2024)
    Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
    Leukemia, 38 (4), 712-719
    DOI 10.1038/s41375-024-02153-6, PubMed 38287133
16. Dimopoulos MA, Voorhees PM, Schjesvold F, Cohen YC, Hungria V, Sandhu I, Lindsay J, Baker RI, Suzuki K, Kosugi H, Levin MD, Beksac M, Stockerl-Goldstein K, Oriol A, Mikala G, Garate G, Theunissen K, Spicka I, Mylin AK, Bringhen S, Uttervall K, Pula B, Medvedova E, Cowan AJ, Moreau P et al. (2024)
    Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
    N Engl J Med, 392 (18), 1777-1788
    DOI 10.1056/NEJMoa2409029, PubMed 39652675
17. Domingos V, Nezvalova-Henriksen K, Dadkhah A, Moreno-Martinez ME, Ben Hassine K, Pires V, Kröger N, Bauters T, Hassan M, Duncan N, Kalwak K, Ansari M, Langebrake C, Admiraal R (2024)
    A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
    Bone Marrow Transplant, 59 (12), 1641-1653
    DOI 10.1038/s41409-024-02413-0, PubMed 39271948
18. Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Yañez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poiré X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O et al. (2024)
    Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Haematologica, 109 (5), 1608-1613
    DOI 10.3324/haematol.2023.284359, PubMed 38205539
19. Fageräng B, Cyranka L, Schjalm C, McAdam KE, Larsen CS, Heinzelbecker J, Gedde-Dahl T, Würzner R, Espevik T, Tjønnfjord GE, Garred P, Barratt-Due A, Tvedt THA, Mollnes TE (2024)
    The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation
    Front Immunol, 15, 1422370
    DOI 10.3389/fimmu.2024.1422370, PubMed 38938578
20. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 781-787
    DOI 10.1038/s41375-024-02145-6, PubMed 38278960
21. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 925
    DOI 10.1038/s41375-024-02184-z, PubMed 38418611
22. Giebel S, Labopin M, Peric Z, Passweg J, Blaise D, Salmenniemi U, Beauvais D, Reményi P, Chevallier P, Mielke S, Gedde-Dahl T, Cornelissen JJ, Balsat M, Bug G, Bazarbachi A, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
    Transplant Cell Ther, 31 (1), 14.e1-14.e10
    DOI 10.1016/j.jtct.2024.07.016, PubMed 39069077
23. Gjærde LK, Brück O, Gagelmann N, Gavriilaki E, Inngjerdingen M, Keranen M, Kisch A, Myhre AE, Olivieri A, Perez-Simon JA, Perovic D, Perovic V, Piekarska A, Pulanic D, Rathje K, Van Veen S, Dachy G, Moiseev I, Penack O, Peric Z, Greinix H, Lee SJ, Wolff D, Schoemans H (2024)
    Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
    Bone Marrow Transplant, 59 (10), 1477-1479
    DOI 10.1038/s41409-024-02374-4, PubMed 39020019
24. Grdinic AG, Radovanovic S, Gleditsch J, Jørgensen CT, Asady E, Pettersen HH, Delibasic B, Ghanima W (2024)
    Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy
    J Thromb Haemost, 22 (4), 1094-1104
    DOI 10.1016/j.jtha.2023.12.034, PubMed 38184201
25. Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T (2024)
    Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
    EJHaem, 5 (1), 117-124
    DOI 10.1002/jha2.842, PubMed 38406518
26. Guièze R, Eikema DJ, Koster L, Schetelig J, Sengeloev H, Passweg J, Finke J, Arat M, Broers AEC, Stölzel F, Byrne J, Castilla-Llorente C, Dreger P, Eder M, Gedde-Dahl T, Kröger N, Ribera Santasusana JM, Richardson D, Rambaldi A, Yañez L, Van Gelder M, Drozd-Sokolowska J, Raj K, Yakoub-Agha I, Tournilhac O et al. (2024)
    Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant, 59 (7), 950-956
    DOI 10.1038/s41409-024-02256-9, PubMed 38503942
27. Halstensen TD, Hardeland C, Ghanima W, Grøndahl VA, Hubin A, Tavoly M (2024)
    Development and internal validation of a simple clinical score for the estimation of the probability of deep vein thrombosis in outpatient emergency department patients
    Res Pract Thromb Haemost, 8 (8), 102608
    DOI 10.1016/j.rpth.2024.102608, PubMed 39717281
28. Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I (2024)
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement
    J Infect, 89 (1), 106176
    DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
29. Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH (2024)
    Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021
    Clin Lymphoma Myeloma Leuk, 25 (1), e62-e69
    DOI 10.1016/j.clml.2024.07.015, PubMed 39191633
30. Hamnvik LHD, Tjønnfjord GE, Spetalen S, Dalgaard J (2024)
    Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report
    J Med Case Rep, 18 (1), 245
    DOI 10.1186/s13256-024-04562-8, PubMed 38736000
31. Harrison SP, Baumgarten SF, Chollet ME, Stavik B, Bhattacharya A, Almaas R, Sullivan GJ (2024)
    Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
    J Pediatr Gastroenterol Nutr, 78 (5), 1047-1058
    DOI 10.1002/jpn3.12195, PubMed 38529852
32. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Tavoly M, Gleditsch J, Johannessen HH (2024)
    Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study
    Res Pract Thromb Haemost, 8 (2), 102366
    DOI 10.1016/j.rpth.2024.102366, PubMed 38562511
33. Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
    Epigenetic aging of human blood cells is influenced by the age of the host body
    Aging Cell, 23 (5), e14112
    DOI 10.1111/acel.14112, PubMed 38439206
34. Holm S, Michelsen AE, Schultz NH, Ueland T, Reikvam H, Holme PA, Aukrust P, Halvorsen B (2024)
    Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report
    Scand J Clin Lab Invest, 84 (6), 425-427
    DOI 10.1080/00365513.2024.2400663, PubMed 39264796
35. Holme PA, Blatný J, Chowdary P, Lassila R, O'Connell N, Hermans C, Álvarez Román MT, Négrier C, Coppola A, Oldenburg J (2024)
    Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
    Haemophilia, 30 (5), 1109-1114
    DOI 10.1111/hae.15031, PubMed 38986684
36. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2024)
    Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Haemophilia, 30 (2), 388-394
    DOI 10.1111/hae.14930, PubMed 38229269
37. Imbery JF, Wiik C, Heinzelbecker J, Jebsen JK, Dobbing MK, Bottini N, Stanford SM, Munthe LA, Tjønnfjord GE, Tveita A, Szodoray P, Nakken B (2024)
    CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
    Mol Ther Oncol, 32 (3), 200841
    DOI 10.1016/j.omton.2024.200841, PubMed 39474602
38. Iversen PO, Gueant JL, Oussalah A, Refsum H, Nexo E, Tjønnfjord GE, Qvigstad C (2024)
    Heterozygous Mutations in Both the AMN and CBS Genes: Double Haploinsufficiency as an Unusual Cause of Vitamin B₁₂ Deficiency-A Case Report
    Clin Case Rep, 12 (11), e9600
    DOI 10.1002/ccr3.9600, PubMed 39582727
39. Kakwangire P, Atukunda P, Ngari M, Westerberg AC, Iversen PO, Muhoozi G (2024)
    Long-term effects on depressive symptoms among Ugandan mothers - Findings from a follow-up of a cluster-randomized education trial in a rural low-resource setting
    J Affect Disord, 351, 598-606
    DOI 10.1016/j.jad.2024.01.263, PubMed 38307132
40. Kakwangire P, Muhoozi G, Ngari M, Matovu N, Westerberg AC, Iversen PO, Atukunda P (2024)
    8-Year Follow-up of a Maternal Education Trial in a Low-Resource Setting
    Pediatrics, 153 (4)
    DOI 10.1542/peds.2023-063352, PubMed 38505933
41. Kakwangire P, Ngari M, Muhoozi G, Westerberg AC, Atukunda P, Iversen PO (2024)
    Associations between sociodemographic exposures, growth and development during infancy with development at the age of eight years among children: Analysis of a maternal education trial in rural Uganda
    J Glob Health, 14, 04228
    DOI 10.7189/jogh.14.04228, PubMed 39641314
42. Kamudoni PR, Kaunda L, Tharrey M, Mphande M, Chithambo S, Ferguson E, Shi Z, Mdala I, Maleta K, Munthali A, Holmboe-Ottesen G, Iversen PO (2024)
    Context-Tailored Food-Based Nutrition Education and Counseling for Pregnant Women to Improve Birth Outcomes: A Cluster-Randomized Controlled Trial in Rural Malawi
    Curr Dev Nutr, 8 (12), 104506
    DOI 10.1016/j.cdnut.2024.104506, PubMed 39654971
43. Kardel KR, Iversen PO, Kaaya AN, Muhoozi G, Veierød MB, Wangen KR, Børøsund E, Friberg PA (2024)
    A pragmatic randomized trial to examine the effect of combining healthy diet with mindfulness cognitive therapy to reduce depressive symptoms among university students in a low-resource setting: protocol for the NutriMind Project
    BMC Psychiatry, 24 (1), 610
    DOI 10.1186/s12888-024-06056-9, PubMed 39261786
44. Kleftogiannis D, Gavasso S, Tislevoll BS, van der Meer N, Motzfeldt IKF, Hellesøy M, Gullaksen SE, Griessinger E, Fagerholt O, Lenartova A, Fløisand Y, Schuringa JJ, Gjertsen BT, Jonassen I (2024)
    Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry
    iScience, 27 (7), 110261
    DOI 10.1016/j.isci.2024.110261, PubMed 39021803
45. Koroma AS, Stephenson KB, Iversen PO, Manary MJ, Hendrixson DT (2024)
    The Effect of Breastfeeding Practices of Undernourished Mothers in Rural Sierra Leone on Infant Growth and Mortality
    Children (Basel), 11 (2)
    DOI 10.3390/children11020233, PubMed 38397345
46. Lin Y, Qiu L, Usmani S, Joo CW, Costa L, Derman B, Du J, Einsele H, Fernandez de Larrea C, Hajek R, Ho PJ, Kastritis E, Martinez-Lopez J, Mateos MV, Mikhael J, Moreau P, Nagarajan C, Nooka A, O'Dwyer M, Schjesvold F, Sidana S, van de Donk NW, Weisel K, Zweegman S, Raje N et al. (2024)
    Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
    Lancet Oncol, 25 (8), e374-e387
    DOI 10.1016/S1470-2045(24)00094-9, PubMed 38821074
47. Loke J, Labopin M, Craddock C, Socié G, Gedde-Dahl T, Blaise D, Forcade E, Salmenniemi U, Huynh A, Versluis J, Yakoub-Agha I, Labussière-Wallet H, Maertens J, Passweg J, Bulabois CE, Gabellier L, Mielke S, Castilla-Llorente C, Deconinck E, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
    Cancer, 130 (15), 2642-2651
    DOI 10.1002/cncr.35308, PubMed 38581695
48. Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F, Nordic Myeloma Study Group (2024)
    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
    Blood Cancer J, 14 (1), 65
    DOI 10.1038/s41408-024-01046-2, PubMed 38622134
49. Małecka A, Østlie I, Trøen G, Małecki J, Delabie J, Tierens A, Munthe LA, Berentsen S, Tjønnfjord GE (2024)
    Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease
    Clin Exp Immunol, 216 (1), 45-54
    DOI 10.1093/cei/uxad135, PubMed 38133636
50. McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T (2024)
    Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
    Heliyon, 10 (1), e24026
    DOI 10.1016/j.heliyon.2024.e24026, PubMed 38283244
51. Mohty R, Bazarbachi AH, Labopin M, Esteve J, Kröger N, Cornelissen JJ, Blaise D, Socié G, Maury S, Ganser A, Gedde-Dahl T, von dem Borne P, Bourhis JH, Bulabois CE, Yakoub-Agha I, Pabst C, Nguyen S, Chevallier P, Huynh A, Bazarbachi A, Nagler A, Ciceri F, Mohty M (2024)
    Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
    Bone Marrow Transplant, 59 (11), 1534-1541
    DOI 10.1038/s41409-024-02384-2, PubMed 39143183
52. Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Clay J, Halahleh K, Skorobogatova E, Sanz J, Passweg J, Mielke S, Ryhänen S, Carpenter B, Gedde-Dahl T, Tholouli E, Fanin R, Lewalle P, Kulasekararaj A et al. (2024)
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
    Blood, 144 (3), 323-333
    DOI 10.1182/blood.2024024173, PubMed 38643511
53. Moukalled N, Labopin M, Versluis J, Socié G, Blaise D, Salmenniemi U, Rambaldi A, Gedde-Dahl T, Tholouli E, Kröger N, Bourhis JH, Von Dem Borne P, Daguindau E, Forcade E, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M (2024)
    Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
    Am J Hematol, 99 (3), 360-369
    DOI 10.1002/ajh.27187, PubMed 38165072
54. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Strandberg K, Tjønnfjord GE, Holme PA (2024)
    Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
    Res Pract Thromb Haemost, 8 (8), 102611
    DOI 10.1016/j.rpth.2024.102611, PubMed 39807249
55. Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M (2024)
    Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (7), 1012-1021
    DOI 10.1038/s41409-024-02284-5, PubMed 38615143
56. Nagler A, Ngoya M, Galimard JE, Labopin M, Blau IW, Kröger N, Gedde-Dahl T, Schroeder T, Burns D, Salmenniemi U, Rambaldi A, Choi G, Peffault de Latour R, Vydra J, Sengeloev H, Eder M, Mielke S, Forcade E, Kulagin A, Ciceri F, Mohty M (2024)
    Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 99 (9), 1732-1745
    DOI 10.1002/ajh.27383, PubMed 38856236
57. Ngari M, Mwangome M, Ouma N, Nyaguara A, Mturi N, Obiero C, Kamau A, Walson JL, Iversen PO, Maitland K, Snow RW, Berkley J (2024)
    Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study
    BMJ Glob Health, 9 (10)
    DOI 10.1136/bmjgh-2024-016600, PubMed 39433400
58. Nielsen LK, Schjesvold F, Möller S, Guldbrandsen N, Hansson M, Remes K, Peceliunas V, Abildgaard N, Gregersen H, King MT (2024)
    Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    J Patient Rep Outcomes, 8 (1), 15
    DOI 10.1186/s41687-024-00691-2, PubMed 38315268
59. Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Schjesvold F (2024)
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
    Blood Cancer J, 14 (1), 60
    DOI 10.1038/s41408-024-01047-1, PubMed 38594252
60. Oldenburg J, Hay C, Peyvandi F, Tagliaferri A, Holme PA, Álvarez-Román MT, Biron-Andréani C, Malmström H, Bystrická L, Lethagen S, A‐SURE Study Group (2024)
    Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study
    Eur J Haematol, 114 (2), 248-257
    DOI 10.1111/ejh.14309, PubMed 39434416
61. Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsæther MR (2024)
    Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
    Cancer Genomics Proteomics, 21 (3), 272-284
    DOI 10.21873/cgp.20446, PubMed 38670586
62. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
    Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
    Anticancer Res, 44 (4), 1389-1397
    DOI 10.21873/anticanres.16935, PubMed 38537997
63. Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH et al. (2024)
    Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
    Cancers (Basel), 16 (5)
    DOI 10.3390/cancers16051024, PubMed 38473382
64. Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
    The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
    Commun Med (Lond), 4 (1), 231
    DOI 10.1038/s43856-024-00650-4, PubMed 39533001
65. Pawlyn C, Schjesvold FH, Cairns DA, Wei LJ, Davies F, Nadeem O, Abdulhaq H, Mateos MV, Laubach J, Weisel K, Ludwig H, Rajkumar SV, Sonneveld P, Jackson G, Morgan G, Richardson PG (2024)
    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
    Blood Cancer J, 14 (1), 134
    DOI 10.1038/s41408-024-01109-4, PubMed 39134544
66. Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Blood Cancer J, 14 (1), 45
    DOI 10.1038/s41408-024-01032-8, PubMed 38485723
67. Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Leukemia, 38 (5), 1156-1163
    DOI 10.1038/s41375-024-02225-7, PubMed 38538862
68. Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
    Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
    Eur J Haematol, 112 (5), 731-742
    DOI 10.1111/ejh.14164, PubMed 38192186
69. Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV (2024)
    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
    Haematologica, 109 (3), 895-905
    DOI 10.3324/haematol.2023.283509, PubMed 37646660
70. Qvigstad C, Sørensen LQ, Tjønnfjord GE, Holme PA, Age-related DeVelopments ANd ComorbiditiEs in hemophilia Working Group (2024)
    The association between unemployment and treatment among adults with hemophilia
    Res Pract Thromb Haemost, 8 (5), 102514
    DOI 10.1016/j.rpth.2024.102514, PubMed 39188890
71. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME (2024)
    Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
    Drugs R D, 24 (3), 359-381
    DOI 10.1007/s40268-024-00481-7, PubMed 39162954
72. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME (2024)
    Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
    Drugs R D, 25 (1), 89-98
    DOI 10.1007/s40268-024-00494-2, PubMed 39702563
73. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME (2024)
    Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII
    Acta Haematol, 148 (1), 58-67
    DOI 10.1159/000538702, PubMed 38599195
74. Richardson PG, Perrot A, Miguel JS, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Macé S, Zhang R, Dubin F, Morisse MC, Anderson KC (2024)
    Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Haematologica, 109 (7), 2239-2249
    DOI 10.3324/haematol.2023.284325, PubMed 38299578
75. Rodriguez-Otero P, Usmani S, Cohen AD, van de Donk NWCJ, Leleu X, Gállego Pérez-Larraya J, Manier S, Nooka AK, Mateos MV, Einsele H, Minnema M, Cavo M, Derman BA, Puig N, Gay F, Ho PJ, Chng WJ, Kastritis E, Gahrton G, Weisel K, Nagarajan C, Schjesvold F, Mikhael J, Costa L, Raje NS et al. (2024)
    International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
    Lancet Oncol, 25 (5), e205-e216
    DOI 10.1016/S1470-2045(24)00043-3, PubMed 38697166
76. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 3455
    DOI 10.1038/s41598-024-53919-y, PubMed 38342941
77. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Publisher Correction: Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 9213
    DOI 10.1038/s41598-024-59915-6, PubMed 38649502
78. Rosenberg T, Möller S, Abildgaard N, Nørgaard JN, Lysén A, Tsykonova G, Joao C, Vangsted A, Schjesvold F, Nielsen LK (2024)
    Health-Related Quality of Life During Carfilzomib-Lenalidomide-Dexamethasone Consolidation: Findings From the Multiple Myeloma CONPET Study
    Eur J Haematol, 114 (3), 517-527
    DOI 10.1111/ejh.14358, PubMed 39638553
79. Røed-Undlien H, Schultz NH, Amundsen EK, Wollmann BM, Molden E, Akerkar RR, Bjørnstad JL (2024)
    Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay?
    Int J Lab Hematol, 46 (5), 946-952
    DOI 10.1111/ijlh.14311, PubMed 38808488
80. Røed-Undlien H, Schultz NH, Husebråten IM, Wollmann BM, Akerkar RR, Molden E, Amundsen EK, Bjørnstad JL (2024)
    Apixaban removal during emergency surgery for type A acute aortic dissection: a prospective cohort study
    Int J Surg, 110 (12), 7782-7790
    DOI 10.1097/JS9.0000000000002137, PubMed 39806740
81. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2024)
    Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>
    J Cardiothorac Vasc Anesth, 38 (7), 1606-1607
    DOI 10.1053/j.jvca.2024.03.039, PubMed 38580477
82. Røra M, Solberg MS, Moore KLF, Slørdahl TS (2024)
    Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience
    EJHaem, 5 (4), 669-676
    DOI 10.1002/jha2.928, PubMed 39157600
83. Rørvik SD, Torkildsen S, Bruserud Ø, Tvedt THA (2024)
    Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification
    Ann Hematol, 103 (4), 1103-1119
    DOI 10.1007/s00277-024-05680-5, PubMed 38443661
84. Scheid C, Eikema DJ, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden P, Raj K, Drozd-Sokolowska J et al. (2024)
    Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
    Blood, 144 (4), 445-456
    DOI 10.1182/blood.2023022273, PubMed 38728380
85. Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P (2024)
    Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Haematologica, 109 (7), 2331-2336
    DOI 10.3324/haematol.2023.284635, PubMed 38426292
86. Sefland Ø, Gullaksen SE, Omsland M, Reikvam H, Galteland E, Tran HTT, Spetalen S, Singh SK, Van Zeeburg HJT, Van De Loosdrecht AA, Gjertsen BT (2024)
    Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease
    Cytometry B Clin Cytom, 106 (6), 485-496
    DOI 10.1002/cyto.b.22197, PubMed 39078053
87. Shaw JR, Nopp S, Stavik B, Youkhana K, Michels AL, Kennes S, Rak J, Ten Cate H (2024)
    Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle
    J Am Heart Assoc, 14 (1), e038782
    DOI 10.1161/JAHA.124.038782, PubMed 39719414
88. Sletten M, Skogstrøm KB, Lind SM, Tinholt M, Stavik B, Rayner S, Iversen N (2024)
    Elevated TFPI is a prognostic factor in hepatocellular carcinoma: Putative role of miR-7-5p and miR-1236-3p
    Thromb Res, 241, 109073
    DOI 10.1016/j.thromres.2024.109073, PubMed 38945092
89. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A et al. (2024)
    A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
    Future Oncol, 20 (38), 3043-3063
    DOI 10.1080/14796694.2024.2394323, PubMed 39287147
90. Stevanovic S, Dalmao-Fernandez A, Mohamed D, Nyman TA, Kostovski E, Iversen PO, Savikj M, Nikolic N, Rustan AC, Thoresen GH, Kase ET (2024)
    Time-dependent reduction in oxidative capacity among cultured myotubes from spinal cord injured individuals
    Acta Physiol (Oxf), 240 (7), e14156
    DOI 10.1111/apha.14156, PubMed 38711362
91. Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P, Xhaard A, Mielke S, Neven B, Snowden JA, Dalle JH, Rubio MT, Crawley C, Maertens J, Kuball J, Chevallier P, Michel G, Gabriel M, Burns D, Wynn RF, Renard C et al. (2024)
    Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (10), 1402-1412
    DOI 10.1038/s41409-024-02361-9, PubMed 38987308
92. Tinholt M, Tekpli X, Torland LA, Tahiri A, Geisler J, Kristensen V, Sandset PM, Iversen N (2024)
    The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
    J Thromb Haemost, 22 (5), 1319-1335
    DOI 10.1016/j.jtha.2024.01.003, PubMed 38237862
93. Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P et al. (2024)
    Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
    J Clin Oncol, 42 (12), 1378-1390
    DOI 10.1200/JCO.23.01159, PubMed 38232336
94. van der Maas NG, Versluis J, Nasserinejad K, van Rosmalen J, Pabst T, Maertens J, Breems D, Manz M, Cloos J, Ossenkoppele GJ, Floisand Y, Gradowska P, Löwenberg B, Huls G, Postmus D, Pignatti F, Cornelissen JJ (2024)
    Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
    Blood Cancer J, 14 (1), 56
    DOI 10.1038/s41408-024-01037-3, PubMed 38538587
95. Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
    Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
    Ther Drug Monit, 46 (3), 416-417
    DOI 10.1097/FTD.0000000000001209, PubMed 38648662
96. Viermyr HK, Halvorsen B, Sagen EL, Michelsen AE, Barrat-Due A, Kåsine T, Nezvalova-Henriksen K, Dyrhol-Riise AM, Nor‐Solidarity Consortium, Lerum TV, Müller F, Tonby K, Tveita A, Aukrust P, Trøseid M, Ueland T, Dahl TB (2024)
    High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 296 (3), 249-259
    DOI 10.1111/joim.13820, PubMed 39011800
97. Wang HL, Siow R, Schmauck-Medina T, Zhang J, Sandset PM, Filshie C, Lund Ø, Partridge L, Bergersen LH, Juel Rasmussen L, Palikaras K, Sotiropoulos I, Storm-Mathisen J, Rubinsztein DC, Spillantini MG, De Zeeuw CI, Watne LO, Vyhnalek M, Veverova K, Liang KX, Tavernarakis N, Bohr VA, Yokote K, Saarela J, Nilsen H et al. (2024)
    Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies
    J Gerontol A Biol Sci Med Sci, 79 (4)
    DOI 10.1093/gerona/glae029, PubMed 38289789
98. Wang J, Sufar EK, Bernhoft A, Seal C, Rempelos L, Hasanaliyeva G, Zhao B, Iversen PO, Baranski M, Volakakis N, Leifert C (2024)
    Mycotoxin contamination in organic and conventional cereal grain and products: A systematic literature review and meta-analysis
    Compr Rev Food Sci Food Saf, 23 (3), e13363
    DOI 10.1111/1541-4337.13363, PubMed 38720588
99. Westerberg NS, Atneosen-Åsegg M, Melheim M, Chollet ME, Harrison SP, Siller R, Sullivan GJ, Almaas R (2024)
    Effect of hypoxia on aquaporins and hepatobiliary transport systems in human hepatic cells
    Pediatr Res, 97 (1), 195-201
    DOI 10.1038/s41390-024-03368-0, PubMed 38951656
100. Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T, Blaise D, Socie G, Forcade E, Salmenniemi U, Maury S, Versluis J, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
     Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
     Blood Cancer J, 14 (1), 85
     DOI 10.1038/s41408-024-01072-0, PubMed 38802349
101. Ye Y, Labopin M, Gérard S, Yakoub-Agha I, Blau IW, Aljurf M, Forcade E, Gedde-Dahl T, Burns D, Vydra J, Halahleh K, Hamladji RM, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Zhao Y, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
     Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
     Am J Hematol, 99 (7), 1290-1299
     DOI 10.1002/ajh.27342, PubMed 38654658
102. Zaboras Z, Jørgensen CT, Stensvold A, Pettersen HH, Grdinic AG, Brækkan SK, Ghanima W, Tavoly M (2024)
     Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
     TH Open, 8 (1), e132-e140
     DOI 10.1055/s-0044-1782219, PubMed 38532938
103. Aarstad HH, Moe SEE, Lybak S, Bruserud Ø, Tvedt THA, Aarstad HJ (2024)
     Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival
     Cancers (Basel), 16 (8)
     DOI 10.3390/cancers16081484, PubMed 38672565